Embryotools achieves the world’s first pregnancy with a new nuclear transfer technique for treating infertility Blog Post

Researchers from the Spanish centre Embryotools —with headquarters in the Barcelona Science Park (Parc Científic de Barcelona, PCB) — are participating in a landmark scientific event in Greece that will shape the future of assisted reproduction. In a pilot clinical trial conducted on women, which is being sponsored by the assisted reproduction centre Institute of Life in Athens, Spanish scientists have achieved the world’s first pregnancy that uses the Maternal Spindle Transfer technique to solve problems of infertility.

 

Whole Genix wins the 2018 Mediterráneo Excellente Prize for Medical Innovation Blog Post

The company Whole Genix, headquartered in the Barcelona Science Park, received the 2018 Mediterráneo Excelente Prize in the Medical Innovation category. This award was received during the gala marking the IV edition of these prizes, held on Friday in Hotel Arts in Barcelona. With these awards, the editorial group El Suplemento aims to assess and highlight entrepreneurial, scientific and cultural talent, as well as social and charity initiatives undertaken by companies, institutions and professionals from the Mediterranean Arc.

 

Researchers at IRB Barcelona explain the origin of the mysterious periodicity of the genome Blog Post

A team of scientists led by Núria López-Bigas –ICREA Research Professor and head of the Barcelona Biomedical Genomics Lab at the Institute for Research in Biomedicine (IRB Barcelona)– have found an explanation for a periodicity in the sequence of the genomes of all eukaryotes, from yeast to humans. The results published in the journal Cell offer an alternative explanation to the one based on natural selection, which has been accepted by the scientific community to date.

 

IBEC and IRB Barcelona projects awarded funds from the 2017 edition of La Marató de TV3 Blog Post

Yesterday, La Fundació  Marató de TV3 announced the 36 projects awarded funding in the 2017 edition of the telethon, dedicated to infectious diseases. Among them is a project headed by Ernest Giralt, from the Institute for Research in Biomedicine (IRB Barcelona) and Jordi Vila, from the Barcelona Institute for Global Health (ISGlobal), and two projects led by Xavier Fernandez-Busquets and Antonio Juarez from the Institute for Bioengineering of Catalonia (IBEC).

 

Researchers from CNAG-CRG and IDIBAPS receive a €8.3 million ERC Synergy Grant Blog Post

The European Research Council (ERC) today announced the results of the 2018 ERC Synergy Grants Call. A project, the BCLL@las, of four research groups from the Centro Nacional de Análisis Genómico (CNAG-CRG) –based in the Barcelona Science Park and integrated into the Centre for Genomic Regulation (CRG)– and the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) have received this prestigious grant to unravel the genomics and epigenomics of chronic lymphocytic leukemia – the most frequent adult leukemia in the Western world– at unprecedented resolution using single-cell analysis. 

 

A study identifies forty genes related to aggressive behaviour Blog Post

An international study published in the journal Molecular Psychiatry has identified forty genes related to aggressive behaviour in humans and mice. Participants in the study, which could contribute to shape future pharmacological targets, are the researchers Bru Cormand and Noèlia Fernàndez Castillo, from the Faculty of Biology at the University of Barcelona and the Institute of Biomedicine of the UB (IBUB), present at the Barcelona Science Park.

 

Starts the third edition BIYSC Blog Post

Today and until July 20 will take place the third edition of the Barcelona International Youth Science Challenge (BIYSC), an international program of excellence for young people passionate about science organized by Fundació Catalunya–La Pedrera and with the support of Fundació Víctor Grífols i Lucas. Once more, Institute for Bioengineering of Catalonia (IBEC) and the Institute for Research in Biomedicine (IRB Barcelona) –both headquartered at the Barcelona Scientific Park–  participate in the event. The objective of the initiative is to stimulate the talent of pre-university youth from around the world and connect them with leading researchers from international research centers based in Barcelona to promote their enthusiasm for science.

 

Biomedical industry in Catalonia raises €102 million in investment in 2017 Blog Post

Catalan biomedical companies attracted €102 million in investment in 2017, with €3.4 million per operation, on average. This will allow them to push forward in the development of drugs and innovative medical technology, as reflected in the Study on investment in the Biomedical industry in Catalonia: Achievements and future challenges presented by CataloniaBio & HealthTech, based in Barcelona Science Park, and EY on Tuesday at the Círculo de Economía in Barcelona. The event drew a crowd of more than 60 entrepreneurs, investors and professionals from the sector.

 

Bionure initiates a Phase 1 clinical trial of its lead compound BN201 in the United Kingdom Blog Post

Bionure, a biotech company based in the Barcelona Science Park that develops neuroprotectant agents to treat neurodegenerative diseases primarily focusing on rare ophthalmologic diseases, announces today the initiation of a Phase 1 clinical trial of its lead compound BN201 in the United Kingd. BN201 is a first-in-class treatment that promotes remyelination and neuroprotection, offering a game-changing solution for neurodegenerative diseases. Both actions make BN201 a promising solution for rare ophthalmologic diseases  and open a research pathway to treat other neurodegenerative diseases such as Multiple Sclerosis (MS). 

 

DTI Foundation: A decade promoting research and training in donation and transplant Blog Post

Yesterday, DTI Foundation (Donation &Transplantation Institute) celebrated its 10th anniversary at Barcelona Science Park. The Foundation —created in Barcelona in 2008— was conceived with the aim of providing consultancy, training and support to professionals from public and private organisations in creating, developing and strengthening networks, programmes and services in the area of organ, tissue and human cell donation and transplantation worldwide. Since its formation, the organization has trained over 14,000 healthcare professionals in the area of organ and tissue donation and transplantation in over 100 countries worldwide.